Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-84.69	54.25	-354.26
Graham Fair Price	16.05	19.75	17.02
PEG	-84.67	0.52	-3.36
Price/Book	1.69	3.11	3.06
Price/Cash Flow	554.18	-59.65	9.12
Prices/Earnings	-19.20	24.24	30.01
Price/Sales	-27.18	20.48	28.13
Price/FCF	554.18	-59.65	9.12
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	36.09	0.75	0.55
Operating Margin	57.22	0.39	-0.25
ROA	37.78	< 0.005	< 0.005
ROE	0.03	0.03	25.87
ROIC	< 0.005	0.02	101.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	-0.07	-20.35
Dividends QOQ	0.02	-0.02	0.01
EBIT QOQ	0.17	3.27	1778.43
EPS QOQ	-0.09	0.47	427.06
FCF QOQ	3.62	-1.16	-67.93
Revenue QOQ	-0.03	0.45	1297.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	1484.89	993.36	-33.10
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.59	0.57	-4.35
Quick Ratio	1485.74	10.89	-99.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.47	23.24	3.44
Cash	37.07	27.05	-27.02
Capex	-0.03	-0.08	-136.25
Free Cash Flow	7.54	-1.21	-83.92
Revenue	2.45	3.53	44.45
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	8.31	2.87	-65.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-41.49	8.20	-80.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating